Is ELEV or EQR a better dividend investment in 2026?

ELEV currently yields 547.95% with a 5% 5-year dividend growth rate. EQR yields 5.87% with 5% growth. The better choice depends on your goal: ELEV offers higher current income.

What is the dividend yield difference between ELEV and EQR?

ELEV has a forward dividend yield of 547.95% ($2.00/share annually). EQR yields 5.87% ($3.47/share annually). The yield gap is 542.08 percentage points.

Home › Compare › ELEV vs EQR

ELEV vs EQR: Dividend Comparison 2026

ELEV yields 547.95% · EQR yields 5.87%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 ELEV wins by $125545.50M in total portfolio value

INVESTMENT

TIME HORIZON10 years

ELEV

● Live price

547.95%

Share price

$0.37

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$125545.55M

Annual income

$92,380,482,230.31

Full ELEV calculator →

EQR

● Live price

5.87%

Share price

$59.15

Annual div

$3.47

5Y div CAGR

15.8%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$47.8K

Annual income

$5,475.61

Full EQR calculator →

Portfolio growth — ELEV vs EQR

📍 ELEV pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	ELEV	EQR
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, ELEV + EQR cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

ELEV pays

EQR pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ELEV

Annual income on $10K today (after 15% tax)

$46,575.34/yr

After 10yr DRIP, annual income (after tax)

$78,523,409,895.76/yr

EQR

Annual income on $10K today (after 15% tax)

$499.01/yr

After 10yr DRIP, annual income (after tax)

$4,654.27/yr

At 15% tax rate, ELEV beats the other by $78,523,405,241.50/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ELEV + EQR for your $10,000?

ELEV: 50%EQR: 50%

100% EQR50/50100% ELEV

Portfolio after 10yr

$62772.80M

Annual income

$46,190,243,852.95/yr

Blended yield

73.58%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on EQR right now

ELEV

Analyst Ratings

Buy

Hold

Sell

Consensus: Hold

Price Target

$9.00

+2365.8% upside vs current

Range: $8.00 — $10.00

Altman Z

-4.8

Piotroski

1/9

EQR

Analyst Ratings

Buy

Hold

Sell

Consensus: Hold

Price Target

$70.35

+18.9% upside vs current

Range: $63.00 — $78.50

Altman Z

1.8

Piotroski

7/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ELEV buys

EQR buys

No recent congressional trades found for ELEV or EQR in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricELEVEQR

Forward yield	547.95% ✓	5.87%
Annual dividend / share	$2.00	$3.47 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	15.8% ✓
Portfolio after 10y	$125545.55M ✓	$47.8K
Annual income after 10y	$92,380,482,230.31 ✓	$5,475.61
Total dividends collected	$122722.76M ✓	$23.0K
Payment frequency	quarterly	quarterly
Sector	Stock	REIT
Analyst consensus	Hold	Hold
Analyst price target	$9.00	$70.35 ✓

Year-by-year: ELEV vs EQR ($10,000, DRIP)

Year	ELEV Portfolio	ELEV Income/yr	EQR Portfolio	EQR Income/yr	Gap
1← crossover	$65,495	$54,794.52	$11,380	$679.82	+$54.1K → ELEV
2	$405,475	$335,396.34	$13,014	$837.25	+$392.5K → ELEV
3	$2,374,450	$1,940,591.70	$14,961	$1,036.20	+$2.36M → ELEV
4	$13,161,259	$10,620,596.57	$17,297	$1,289.22	+$13.14M → ELEV
5	$69,099,868	$55,017,321.36	$20,121	$1,613.15	+$69.08M → ELEV
6	$343,894,398	$269,957,539.26	$23,561	$2,030.84	+$343.87M → ELEV
7	$1,623,590,885	$1,255,623,879.22	$27,783	$2,573.54	+$1623.56M → ELEV
8	$7,277,465,834	$5,540,223,587.11	$33,013	$3,284.39	+$7277.43M → ELEV
9	$30,995,389,120	$23,208,500,677.65	$39,547	$4,223.51	+$30995.35M → ELEV
10	$125,545,548,589	$92,380,482,230.31	$47,791	$5,475.61	+$125545.50M → ELEV

ELEV vs EQR: Complete Analysis 2026

ELEV — Stock

Elevation Oncology, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for the treatment of cancer in genomically defined patient populations in the United States. The company's lead program is the seribantumab, an anti-HER3 monoclonal antibody that is in Phase II CRESTONE trial for the treatment of advanced solid tumors harboring a neuregulin-1 fusion. Elevation Oncology, Inc. was incorporated in 2019 and is based in New York, New York.

Full ELEV Calculator →

EQR — REIT

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, D.C., Seattle, San Francisco, Southern California and Denver.

Full EQR Calculator →

📬

Get this ELEV vs EQR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ELEV vs SCHD ELEV vs JEPI ELEV vs O ELEV vs KO ELEV vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.